Resources

Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.

Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.

Inferring gene expression from cell-free DNA fragmentation profiles
April 1, 2022 | Manuscript
Nature Biopharma Dealmakers: Closing the gap on minimal residual disease detection in cancer
March 29, 2022 | Article
Noninvasive Cell-of-Origin Classification of Diffuse Large B-Cell Lymphoma Using Inferred Gene Expression from Cell-Free DNA Sequencing
December 13, 2021 | Abstract
Concurrent Pembrolizumab with AVD for Untreated Classical Hodgkin Lymphoma
December 13, 2021 | Abstract
Profiling of Circulating Tumor DNA for Noninvasive Disease Detection, Risk Stratification, and MRD Monitoring in Patients with CNS Lymphoma
December 13, 2021 | Abstract
Phase 2 Study of Acalabrutinib Window Prior to Frontline Therapy in Untreated Aggressive B-Cell Lymphoma: Preliminary Results and Correlatives of Response to Acalabrutinib
December 13, 2021 | Abstract